| Literature DB >> 28161695 |
Angelina Passaro1,2, Cecilia Soavi1,2, Uros Marusic3, Enrico Rejc4, Juana M Sanz1, Mario L Morieri1, Edoardo Dalla Nora1, Voyko Kavcic5,6, Marco V Narici7, Carlo Reggiani8, Gianni Biolo9, Giovanni Zuliani1, Stefano Lazzer10,11, Rado Pišot3.
Abstract
Acute stress, as bed rest, was shown to increase plasma level of the neurotrophin brain-derived neurotrophic factor (BDNF) in older, but not in young adults. This increase might represent a protective mechanism towards acute insults in aging subjects. Since computerized cognitive training (CCT) is known to protect brain, herein we evaluated the effect of CCT during bed rest on BDNF, muscle mass, neuromuscular function and metabolic parameters. The subjects that underwent CCT did not show an increase of BDNF after bed rest, and showed an anti-insular modification pattern in metabolism. Neuromuscular function parameters, already shown to beneficiate from CCT, negatively correlated with BDNF in research participants undergoing CCT, while positively correlated in the control group. In conclusion, BDNF increase can be interpreted as a standardized protective mechanism taking place whenever an insult occurs; it gives low, but consistent preservation of neuromuscular function. CCT, acting as an external protective mechanism, seems to modify this standardized response, avoiding BDNF increase or possibly modifying its time course. Our results suggest the possibility of differential neuroprotective mechanisms among ill and healthy individuals, and the importance of timing in determining the effects of protective mechanisms.Entities:
Keywords: BDNF; acute stress; aging; bed rest; cognitive training; metabolism
Mesh:
Substances:
Year: 2017 PMID: 28161695 PMCID: PMC5361671 DOI: 10.18632/aging.101166
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Baseline characteristics of the study population. Data are expressed as mean ± standard deviation
| noCCT (N 8) | CCT (N 8) | P | |
|---|---|---|---|
| Demographic and Anthropometric characteristics | |||
| Age (years) | 59.1±2.5 | 59.1±3.6 | 0.991 |
| BMI (Kg/mq) | 26.9±4.2 | 26.9±5.2 | 0.928 |
| FFM (Kg) | 59.8±6.9 | 64.5±11.7 | 0.355 |
| FM (Kg) | 19.9±4.9 | 16.8±7.4 | 0.360 |
| Metabolic profile | |||
| Total cholesterol (mg/dl) | 212.4±24.4 | 193.8±53.5 | 0.393 |
| LDL cholesterol (mg/dl) | 143.0±18.6 | 134.6±47.2 | 0.648 |
| HDL cholesterol (mg/dl) | 42.1±7.7 | 37.8±5.2 | 0.648 |
| Triglycerides (mg/dl) | 136.5±33.9 | 107.6±51.9 | 0.219 |
| Insulin (mU/I) | 5.7±1.1 | 6.3±4.4 | 0.720 |
| Glucose (mg/dl) | 79.6±9.5 | 76.5±7.5 | 0.489 |
| HOMA IR | 1.12±0.27 | 1.15±0.88 | 0.812 |
| Inflammation/stress markers | |||
| C-reactive protein (mg/dl) | 0.11±0.06 | 0.12±0.13 | 0.815 |
| TNF-alpha | 1.45±2.65 | 4.35±5.60 | 0.211 |
| BDNF (pg/ml) | 37.53±18.58 | 47.81±18.57 | 0.305 |
| Muscular parameters | |||
| QF muscle volume (cm3) | 1663.8±173.4 | 1755.9±277.1 | 0.447 |
| BCM (Kg) | 30.90±4.75 | 33.84±7.01 | 0.353 |
| MM (Kg) | 38.28±5.48 | 41.81±8.41 | 0.346 |
| MEP (W) | 2653.5±566.8 | 2576.7±519.2 | 0.790 |
| MVC (N) | 564.4±120.9 | 524.1±112.2 | 0.518 |
BCM: body cellular mass; BDNF: brain derived neurotrophic factor; BMI: body mass index; CCT: computerized cognitive training; FFM: fat-free mass; FM: fat mass; HDL: high density lipoprotein; HOMA: homeostatic model assessment; LDL: low density lipoprotein; MEP: maximal explosive power of the lower limbs; MM: muscle mass; MVC: maximal voluntary contraction of knee extensors; QF: quadriceps femoris; TNF: tumour necrosis factor.
Figure 1Mean brain-derived neurotrophic factor (BDNF) plasma levels in Computerized Cognitive Training (CCT) group and a no-Computerized Cognitive Training (noCCT) group at BDC (baseline data collection) and BR14 (14th day of bed rest)
There was a significant interaction effect between time and group.
Time and time x group interaction effect on anthropometric and metabolic variables
| Time effect | Time x Group effect | |||||
|---|---|---|---|---|---|---|
| F | P | Partial η2 | F | P | Partial η2 | |
| BMI | 47.898 | 0.787 | 1.264 | 0.281 | 0.089 | |
| FFM | 17.009 | 0.567 | 0.470 | 0.505 | 0.035 | |
| FM | 3.373 | 0.089 | 0.206 | 0.098 | 0.759 | 0.008 |
| Total cholesterol | 18.232 | 0.584 | 0.170 | 0.687 | 0.013 | |
| LDL cholesterol | 15.597 | 0.545 | 0.631 | 0.441 | 0.046 | |
| HDL cholesterol | 0.003 | 0.959 | <0.001 | 4.134 | 0.063 | 0.241 |
| Triglycerides | 2.044 | 0.176 | 0.136 | 1.081 | 0.317 | 0.077 |
| Insulin | 4.236 | 0.062 | 0.261 | 0.275 | 0.610 | 0.022 |
| Glucose | 2.900 | 0.112 | 0.182 | 0.594 | 0.455 | 0.044 |
| HOMA IR | 0.115 | 0.741 | 0.009 | 0.790 | 0.392 | 0.062 |
| C-reactive protein | 2.105 | 0.171 | 0.139 | 0.640 | 0.438 | 0.047 |
| TNF-alpha | 2.581 | 0.132 | 0.166 | 2.127 | 0.168 | 0.141 |
Bold font is used to underline statistically significant results. BMI: body mass index; FFM: fat-free mass; FM: fat mass; HDL: high density lipoprotein; HOMA: homeostasis model assessment; LDL: low density lipoprotein; TNF: tumour necrosis factor.
Paired sample T-test regarding anthropometric/metabolic variables. Data are expressed as mean ± standard deviation
| noCCT (N 8) | P | CCT (N 8) | P | |||
|---|---|---|---|---|---|---|
| Anthropometric characteristics | ||||||
| BMI (Kg/mq) | 26.9±4.2 | 26.2±4.1 | 26.6±5.2 | 25.7±4.7 | ||
| FFM (Kg) | 59.8±6.9 | 56.7±6.8 | 64.5±11.7 | 60.1±8.1 | 0.062 | |
| FM (Kg) | 19.9±4.9 | 20.9±4.8 | 16.8±7.4 | 18.3±9.4 | 0.349 | |
| Metabolic profile | ||||||
| Total cholesterol (mg/dl) | 212.4±24.4 | 183.5±33.5 | 193.8±53.5 | 170.0±49.6 | 0.055 | |
| LDL cholesterol (mg/dl) | 143.0±18.6 | 124.2±30.2 | 134.6±47.2 | 106.3±51.9 | ||
| HDL cholesterol (mg/dl) | 42.1±7.7 | 36.6±9.5 | 0.244 | 37.8±5.2 | 42.9±9.0 | 0.100 |
| Triglycerides (mg/dl) | 136.5±33.9 | 113.7±29.0 | 107.6±51.9 | 104.0±20.3 | 0.840 | |
| Insulin (mU/I) | 5.69±1.11 | 4.85±1.57 | 0.106 | 6.60±4.66 | 6.06±4.30 | 0.313 |
| Glucose (mg/dl) | 79.6±9.5 | 82.4±15.0 | 0.622 | 76.5±7.5 | 83.8±6.1 | |
| HOMA IR | 1.12±0.27 | 1.02±0.44 | 0.469 | 1.27±1.01 | 1.32±1.05 | 0.535 |
| Inflammation/stress markers | ||||||
| C-reactive protein (mg/dl) | 0.11±0.06 | 0.36±.64 | 0.275 | 0.12±0.13 | 1.00±2.14 | 0.315 |
| TNF-alpha | 1.45±2.65 | 1.59±2.98 | 0.319 | 4.35±5.60 | 7.38±10.38 | 0.203 |
Bold font is used to underline statistically significant results. BDC: baseline data collection; BMI: body mass index; BR14: at 14th day of bed rest; CCT: computerized cognitive training; FFM: fat-free mass; FM: fat mass; HDL: high density lipoprotein; HOMA: homeostasis model assessment; LDL: low density lipoprotein; TNF: tumour necrosis factor.
Time and time x group interaction effect on muscle mass and neuromuscular function
| Time effect | Time x Group effect | |||||
|---|---|---|---|---|---|---|
| F | P | Partial η2 | F | P | Partial η2 | |
| QF muscle volume | 79.388 | 0.859 | 0.152 | 0.703 | 0.012 | |
| BCM | 6.326 | 0.327 | 0.149 | 0.706 | 0.011 | |
| MM | 7.601 | 0.369 | 0.192 | 0.669 | 0.015 | |
| MEP | 23.167 | 0.641 | 0.023 | 0.881 | 0.002 | |
| MVC | 13.390 | 0.507 | 1.472 | 0.247 | 0.102 | |
Bold font is used to underline statistically significant results. BCM: body cellular mass; MEP: maximal explosive power of lower limb; MM: muscle mass; MVC: maximal voluntary contraction of the knee extensors; QF: quadriceps femoris.
Paired sample t-test regarding muscle mass and neuromuscular function variables. Data are expressed as mean ± standard deviation
| noCCT (N 8) | P value | CCT (N 8) | P value | |||
|---|---|---|---|---|---|---|
| Quantity measures | ||||||
| BCM (Kg) | 30.9±4.8 | 29.4±4.3 | 33.8±7.0 | 31.8±3.7 | ||
| MM(Kg) | 38.3±5.5 | 36.4±5.1 | 41.8±8.4 | 39.2±4.6 | ||
| QF muscle volume (cm3) | 1663.8±173.4 | 1524.3±196.9 | 1755.9±277.1 | 1603.6±233.4 | ||
| Function measures | ||||||
| MEP (W) | 2653.5±566.8 | 2270.0±571.3 | 2576.7±519.2 | 2216.7±441.4 | ||
| MVC (N) | 564.4±120.9 | 519.6±123.9 | 524.1±112.2 | 435.0±80.9 | 0.104 | |
Bold font is used to underline statistically significant results. BCM: body cellular mass; BDC: baseline data collection; BR14: at 14th day of bed rest; CCT: computerized cognitive training; MEP: maximal explosive power of lower limb; MM: muscle mass; MVC: maximal voluntary contraction of the knee extensors; QF: quadriceps femoris.
Figure 2Correlation between brain-derived neurotrophic factor (BDNF) and maximal explosive power of lower limbs (MEP) on 14th day of bed rest (BR14)
(A) no-Computerized Cognitive Training (noCCT) group, and (B) Computerized Cognitive Training (CCT) group.
Figure 3Schematic hypothetical representation of the possible effects of bed rest and CCT on BDNF release
(A) Bed rest (BR) might act as a low-frequency stimulus inducing, at pre-synaptical level, the transcription of p75NTR, TrkB and proBDNF, which is proteolytically converted in BDNF. Thus, in the synaptical space might be released a high amount of mature BDNF and a low amount of proBDNF; both at post-synaptical and at pre-synaptical level, these molecules bind their specific receptors. BDNF binds to TrkB; at pre-synaptical level this induces the activation of MAPK pathway which, in turn, maintains active the transcription of BDNF. ProBDNF binds minimally to TrkB and principally to p75NTR; its activation at pre-synaptical level, via PIP2 pathway, leads to the suppression of BDNF transcription. Since BDNF amount is higher than proBDNF, the final balanced effect might be the persistant BDNF transcription and activity. This mechanism could be responsible for an increase of BDNF level in synaptic space and consequently in circulation. (B) CCT, acting as an high frequency stimulus, might be responsible for blocking the maturation of BDNF, leading to the release of high amounts of proBDNF and low amounts of BDNF in the synaptic space. In this case proBDNF modulatory effect might prevail on BDNF's leading, in turn, to the suppression of the transcription of BDNF. In this case a rapid and transient increase of BDNF in the synaptic space and in circulation might occur.